Raphaël F. Rousseau
KineMed (United States)(US)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Neuroblastoma Research and Treatments, CAR-T cell therapy research, Virus-based gene therapy research, Immunotherapy and Immune Responses
Most-Cited Works
- → Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma(2009)346 cited
- → Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification(2018)304 cited
- → Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results(2022)211 cited
- → Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells(2003)156 cited
- → Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma(2018)139 cited
- → Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors(2010)126 cited
- → Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma(2003)123 cited
- → Netrin-1 acts as a survival factor for aggressive neuroblastoma(2009)122 cited
- → In VitroandIn VivoAntitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL againstCD33+Acute Myeloid Leukemia(2012)99 cited
- → Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer(2014)93 cited